Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Perkins

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|October 4, 2024
National Council on Radiation Protection (NCRP) 2024 annual meeting:<i>advanced and small modular nuclear power reactors</i><sup></sup>William E Kennedy, Richard A Meserve, Kathryn A Higley, et al.
Texas Dental Journal|July 12, 2012
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
Journal of the American Dental Association (1939)|May 4, 2010
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
Journal of Medicinal Chemistry|March 22, 2007
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft ModelsM Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2020
Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled TrialAhmed A Al-Jaishi, Christopher W McIntyre, Jessica M Sontrop, et al.
Canadian Journal of Kidney Health and Disease|June 15, 2026
Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative ReviewBryn Tannar, Hareth Al-Hellawi, Jessica M Sontrop, et al.
Canadian Journal of Kidney Health and Disease|December 15, 2025
Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial, Lauren Killin, Clara Bohm, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|October 4, 2024
National Council on Radiation Protection (NCRP) 2024 annual meeting:<i>advanced and small modular nuclear power reactors</i><sup></sup>William E Kennedy, Richard A Meserve, Kathryn A Higley, et al.
Texas Dental Journal|July 12, 2012
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
Journal of the American Dental Association (1939)|May 4, 2010
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomasMichael P Rethman, William Carpenter, Ezra E W Cohen, et al.
Journal of Medicinal Chemistry|March 22, 2007
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinaseAndrew A Mortlock, Kevin M Foote, Nicola M Heron, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft ModelsM Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|October 2, 2014
Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptorM Raymond V Finlay, Mark Anderton, Susan Ashton, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2020
Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled TrialAhmed A Al-Jaishi, Christopher W McIntyre, Jessica M Sontrop, et al.
Canadian Journal of Kidney Health and Disease|June 15, 2026
Effects of Increasing the Concentration of Dialysate Magnesium on Cardiovascular Health: A Narrative ReviewBryn Tannar, Hareth Al-Hellawi, Jessica M Sontrop, et al.
Canadian Journal of Kidney Health and Disease|December 15, 2025
Outcomes of Adopting a Higher Versus Lower Concentration of Hemodialysate Magnesium as a Center-Wide Policy (Dial-Mag): A Clinical Research Protocol of a Pragmatic, Registry-Based, Cluster Randomized Trial, Lauren Killin, Clara Bohm, et al.
Pageof 15